New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
What is a breast medicine specialist?

What is a breast medicine specialist?

by Sonya Goins, Mayo Clinic News NetworkCredit: Unsplash/CC0 Public DomainMany people think that a breast health specialist only treats cancer, but the truth is that these doctors handle a wide range
World medicine December 15,2023
What is a breast medicine specialist?

What is a breast medicine specialist?

by Sonya Goins, Mayo Clinic News NetworkCredit: Unsplash/CC0 Public DomainMany people think that a breast health specialist only treats cancer, but the truth is that these doctors handle a wide range
World medicine December 15,2023
Deep learning reveals valuable clues about kidney cancer in pathology slides

Deep learning reveals valuable clues about kidney cancer in pathology slides

byDana-Farber Cancer InstituteCredit: Pixabay/CC0 Public DomainA team of Dana-Farber researchers has identified a potential new way to assess clinically valuable features of clear cell renal cel
World medicine December 15,2023
Deep learning reveals valuable clues about kidney cancer in pathology slides

Deep learning reveals valuable clues about kidney cancer in pathology slides

byDana-Farber Cancer InstituteCredit: Pixabay/CC0 Public DomainA team of Dana-Farber researchers has identified a potential new way to assess clinically valuable features of clear cell renal cel
World medicine December 15,2023
Editorial: Cancer drug development yesterday, today and tomorrow

Editorial: Cancer drug development yesterday, today and tomorrow

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainA new editorial paper was published inOncoscience, titled "Cancer drug development yesterday, today and tomorrow."In this new edi
World medicine December 15,2023
Editorial: Cancer drug development yesterday, today and tomorrow

Editorial: Cancer drug development yesterday, today and tomorrow

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainA new editorial paper was published inOncoscience, titled "Cancer drug development yesterday, today and tomorrow."In this new edi
World medicine December 15,2023
How social media can help to understand treatment experiences of survivors of rare cancers

How social media can help to understand treatment experiences of survivors of rare cancers

byHudson Institute of Medical ResearchL–R: Associate Professor Simon Chu and Maria Alexiadis. Credit: Hudson Institute of Medical ResearchCancer specialists have taken a novel path to advance th
World medicine December 15,2023
How social media can help to understand treatment experiences of survivors of rare cancers

How social media can help to understand treatment experiences of survivors of rare cancers

byHudson Institute of Medical ResearchL–R: Associate Professor Simon Chu and Maria Alexiadis. Credit: Hudson Institute of Medical ResearchCancer specialists have taken a novel path to advance th
World medicine December 15,2023
Screening genes for the right treatment: New hope for children with cancer

Screening genes for the right treatment: New hope for children with cancer

by Children's Cancer Institute AustraliaGraphical Abstract. Credit:Cancer Research(2023). DOI: 10.1158/0008-5472.CAN-22-3702In a landmark study of 125 Australian children with high-ris
World medicine December 14,2023
Screening genes for the right treatment: New hope for children with cancer

Screening genes for the right treatment: New hope for children with cancer

by Children's Cancer Institute AustraliaGraphical Abstract. Credit:Cancer Research(2023). DOI: 10.1158/0008-5472.CAN-22-3702In a landmark study of 125 Australian children with high-ris
World medicine December 14,2023
Scan could guide use of drugs targeting a tumor's 'scaffold' to improve breast cancer treatment

Scan could guide use of drugs targeting a tumor's 'scaffold' to improve breast cancer treatment

byInstitute of Cancer ResearchImage: Normal breast epithelial cells with stained mitochondria (green), microtubules (red) and DNA (blue). Credit: Julia SeroResearchers have found a way to use a
World medicine December 14,2023
Scan could guide use of drugs targeting a tumor's 'scaffold' to improve breast cancer treatment

Scan could guide use of drugs targeting a tumor's 'scaffold' to improve breast cancer treatment

byInstitute of Cancer ResearchImage: Normal breast epithelial cells with stained mitochondria (green), microtubules (red) and DNA (blue). Credit: Julia SeroResearchers have found a way to use a
World medicine December 14,2023
Crosstalk between triple negative breast cancer and microenvironment

Crosstalk between triple negative breast cancer and microenvironment

by Impact Journals LLCActive pharmacological intervention trials in TNBC. Credit: 2023 Smrekar et al.A new review paper was published in the journalOncotargeton March 31, 2023, titled &quo
World medicine December 14,2023
Crosstalk between triple negative breast cancer and microenvironment

Crosstalk between triple negative breast cancer and microenvironment

by Impact Journals LLCActive pharmacological intervention trials in TNBC. Credit: 2023 Smrekar et al.A new review paper was published in the journalOncotargeton March 31, 2023, titled &quo
World medicine December 14,2023
Regorafenib, nivolumab, chemo combo found safe and effective for various cancers, heading to phase 3 trial

Regorafenib, nivolumab, chemo combo found safe and effective for various cancers, heading to phase 3 trial

by Justin Jackson , Medical XpressCredit: Pixabay/CC0 Public DomainResearchers at Memorial Sloan Kettering Cancer Center, New York, have concluded their phase 2 trial of chemotherapy in combination wi
World medicine December 14,2023
Regorafenib, nivolumab, chemo combo found safe and effective for various cancers, heading to phase 3 trial

Regorafenib, nivolumab, chemo combo found safe and effective for various cancers, heading to phase 3 trial

by Justin Jackson , Medical XpressCredit: Pixabay/CC0 Public DomainResearchers at Memorial Sloan Kettering Cancer Center, New York, have concluded their phase 2 trial of chemotherapy in combination wi
World medicine December 14,2023
Breast cancer tumors shown to disrupt the immune system remotely, favoring their own growth

Breast cancer tumors shown to disrupt the immune system remotely, favoring their own growth

byBaylor College of MedicineCredit: Pixabay/CC0 Public DomainResearchers at Baylor College of Medicine and collaborating institutions have identified a strategy cancerous tumors use to remotely
World medicine December 14,2023
Breast cancer tumors shown to disrupt the immune system remotely, favoring their own growth

Breast cancer tumors shown to disrupt the immune system remotely, favoring their own growth

byBaylor College of MedicineCredit: Pixabay/CC0 Public DomainResearchers at Baylor College of Medicine and collaborating institutions have identified a strategy cancerous tumors use to remotely
World medicine December 14,2023
Breast cancer drug shown to reduce recurrence risk

Breast cancer drug shown to reduce recurrence risk

by Issam AHMEDA patient is pictured before a mammography at the Paoli-Calmette cancer institute in France in 2017.Even when the disease is caught early, breast cancer recurrence is relatively commonpl
World medicine December 14,2023
Breast cancer drug shown to reduce recurrence risk

Breast cancer drug shown to reduce recurrence risk

by Issam AHMEDA patient is pictured before a mammography at the Paoli-Calmette cancer institute in France in 2017.Even when the disease is caught early, breast cancer recurrence is relatively commonpl
World medicine December 14,2023
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com